Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Removing an adrenal gland tumor improved a man's blood pressure and stopped his facial hair growth.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Sphingosine 1-phosphate affects inflammation and gene expression in different aorta cells.

Angiopoietin-1 helps hair follicle cells survive and grow, potentially treating hair loss.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Reduced plakoglobin and steroid abuse increase the risk of heart rhythm issues.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

AIMP1 can boost hair growth by increasing stem cell activity.

Vasodilators may worsen abdominal aortic aneurysm.

Angiopoietin-1 helps hair cells survive and grow, making it a potential treatment for hair loss.

Four-amino acid part makes enzyme sensitive to finasteride.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

The KDM1 gene helps Venus flytraps close by managing potassium ions.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.